Eddie Cliff: CAR T-Cell Therapy Outcomes Unchanged by Time of Infusion in LBCL
Edward Cliff/cevr.tuftsmedicalcenter.org

Eddie Cliff: CAR T-Cell Therapy Outcomes Unchanged by Time of Infusion in LBCL

Eddie Cliff, Haematology Registrar at Peter MacCallum Cancer Centre, shared on X:

“Just out Blood Journals Portfolio: AusCART consortium looked at time of infusion for 580 pts with LBCL and found no difference in outcomes for pts receiving morning vs afternoon infusions. What do you reckon.”

Title: Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma

Authors: Mark R Dowling, Edward Robert Scheffer Cliff, Anthony Jeffrey, Catelyn Cashion, Stephen Boyle, Jian Li, Thomas Buss, Ross MacDonald, Anastasia Edelkina, Hamish W Scott, MD, Nicole O’Leary, Michelle Wendy Keir, Safia Belbachir, David A Westerman, Constantine S. Tam, P. Joy Ho, Simon J Harrison, Allison Barraclough, Shafqat Inam, Emily Blyth, Andrea S. Henden, Vinay Vanguru, Michael Dickinson

Read The Full Article

Eddie Cliff

Alex Rampotas, Haematologist at UCL Cancer Institute, shared a post by Eddie Cliff, adding:

“This is very important work. Well done Eddie. Logic prevails.”

Other articles featuring Eddie Cliff on OncoDaily.